Cyclodextrins: their future in drug formulation and delivery

Area of Science:

• Pharmaceutical Sciences
• Supramolecular Chemistry

Background:

• Cyclodextrins (CDs) are cyclic oligosaccharides known for their ability to form inclusion complexes.
• Their unique structure allows them to encapsulate guest molecules, influencing their physicochemical properties.

Purpose of the Study:

• To critically assess the current status of cyclodextrins in pharmaceutical formulation and drug delivery.
• To discuss the potential future applications of cyclodextrins in pharmaceuticals.
• To address common questions regarding the use of cyclodextrins in drug development.

Main Methods:

• Literature review and critical analysis of existing research on cyclodextrins in pharmaceuticals.
• Discussion of key questions related to cyclodextrin applications, including solubilization, stabilization, drug release, pharmacokinetics, and regulatory status.

Main Results:

• Cyclodextrins offer significant advantages for drug solubilization and stabilization compared to alternative methods.
• Modified cyclodextrins are often preferred over parent cyclodextrins due to enhanced properties.
• The release of drugs from cyclodextrin complexes in vivo and the impact on pharmacokinetics are complex but often manageable.

Conclusions:

• Cyclodextrins are valuable tools in pharmaceutical formulation, with established and emerging applications.
• Understanding cyclodextrin-drug interactions is crucial for optimizing drug delivery and therapeutic outcomes.
• Further research and development are expected to expand the role of cyclodextrins in innovative drug products.